Lantheus Holdings, Inc. acquires Meilleur Technologies, Inc. to expand Alzheimer’s diagnostic capabilities
Lantheus Holdings, Inc. acquires Meilleur Technologies, Inc. to expand Alzheimer’s diagnostic capabilities
07/15/24, 12:50 PM
Location
bedforddublinIndustry
therapeutics
biotechnology
health care
therapeutics
biotechnology
health care
Lantheus Holdings, Inc. announced its acquisition of Meilleur Technologies, Inc., which includes the next-generation ß amyloid PET imaging agent NAV-4694. This acquisition expands Lantheus’ Alzheimer’s disease pipeline and strengthens its diagnostic capabilities in line with updated guidelines developed by the National Institute on Aging and the Alzheimer's Association.
Company Info
Location
Bedford, Massachusetts, United States
Company info
Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in New Jersey, Canada and Sweden, Lantheus has been providing radiopharmaceutical solutions for more than 65 years. For more information, visit www.lantheus.com.